✦ LIBER ✦

Introduction: Human Metabolites in Safety Testing (MIST) Issue

✍ Scribed by Guengerich, F. Peter

Book ID: 127364017
Publisher: American Chemical Society
Year: 2009
Tongue: English
Weight: 48 KB
Volume: 22
Category: Article
ISSN: 0893-228X
DOI: 10.1021/tx900003k

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Metabolites in Safety Testing: “MIST” fo

Metabolites in Safety Testing: “MIST” for the Clinical Pharmacologist

✍ Frederick, C B; Obach, R S 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 153 KB

Meeting Report: Metabolites in Safety Te

Meeting Report: Metabolites in Safety Testing (MIST) Symposium—Safety Assessment of Human Metabolites: What’s REALLY Necessary to Ascertain Exposure Coverage in Safety Tests?

✍ Gao, Hongying; Jacobs, Abigail; White, Ronald E.; Booth, Brian P.; Obach, R. Sco 📂 Article 📅 2013 🏛 American Association of Pharmaceutical Scientists 🌐 English ⚖ 148 KB

Drug Metabolites in Safety Testing

✍ Thomas A. Baillie; Mitchell N. Cayen; Hassan Fouda; Ronald J. Gerson; James D. G 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Clearing the MIST (metabolites in safety

Clearing the MIST (metabolites in safety testing) of time: The impact of duration of administration on drug metabolite toxicity

✍ Dennis A. Smith; R. Scott Obach; Dominic P. Williams; B. Kevin Park 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 519 KB

Metabolites in Safety Testing (MIST): Co

Metabolites in Safety Testing (MIST): Considerations of Mechanisms of Toxicity with Dose, Abundance, and Duration of Treatment

✍ Smith, Dennis A.; Obach, R. Scott 📂 Article 📅 2009 🏛 American Chemical Society 🌐 English ⚖ 449 KB

Metabolites in safety testing: metabolit

Metabolites in safety testing: metabolite identification strategies in discovery and development

✍ Angus N. R. Nedderman 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 229 KB

## Abstract The publication of the FDA MIST guidelines in 2008, together with the acknowledged importance of metabolism data for the progression of novel compounds through drug discovery and drug development, has resulted in a renewed focus on the metabolite identification strategies utilised throu